Chemical
Browse
Active Pharmaceutical Ingredients
Bioactive chemicals
Agrochemicals
Search
Chemical Structure
Explore
Chemical Similarity
Transformation
Browse
Prodrugs
Drug Metabolites
Metabolite Datasets
Biochemical Action
Browse
Target Level (ChEMBL)
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Mechanism of action
Search
Mechanism of action
BLAST against human drug target
BLAST against selected species (UniProt)
Exposure
Browse
Monitoring data
Downloads
Web services
Bulk downloads
About
About EcoDrug+
Citing
Data Sources
Contact Us
Versions and log file
Display Options:
Molecule Type
Mechanism of Action
Route of Adminstration
Status
Therapeutic Indication
Number of compounds:
7959
FISETIN
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
FISETIN
×
Maximum Phase:
2
First Approval:
None
UNII:
OO2ABO9578
Molecule Type:
Small molecule
Molecular Formula:
C15H10O6
Molecular Weight:
286.24
AlogP:
2.28
PSA:
111.13
HBD:
4.0
HBA:
#RotB:
1.0
Source:
CAVOSONSTAT
(2)
Small molecule
Alcohol dehydrogenase class III inhibitor
Unknown
Investigational
Unknown
CAVOSONSTAT
×
Maximum Phase:
2
First Approval:
None
UNII:
O2Z8Q22ZE4
Molecule Type:
Small molecule
Molecular Formula:
C16H10ClNO3
Molecular Weight:
299.71
AlogP:
3.96
PSA:
70.42
HBD:
2.0
HBA:
#RotB:
2.0
Source:
ULIXERTINIB
(2)
Small molecule
MAP kinase ERK1 inhibitor
Unknown
Investigational
Unknown
ULIXERTINIB
×
Maximum Phase:
2
First Approval:
None
UNII:
16ZDH50O1U
Molecule Type:
Small molecule
Molecular Formula:
C21H22Cl2N4O2
Molecular Weight:
433.34
AlogP:
4.67
PSA:
90.04
HBD:
4.0
HBA:
#RotB:
7.0
Source:
RALIMETINIB
(2)
Small molecule
MAP kinase p38 alpha inhibitor
Unknown
Investigational
Unknown
RALIMETINIB
×
Maximum Phase:
2
First Approval:
None
UNII:
73I34XW4HD
Molecule Type:
Small molecule
Molecular Formula:
C24H29FN6
Molecular Weight:
420.54
AlogP:
5.55
PSA:
85.41
HBD:
2.0
HBA:
#RotB:
3.0
Source:
S-1360
(2)
Small molecule
Human immunodeficiency virus type 1 integrase inhibitor
Unknown
Investigational
Unknown
S-1360
×
Maximum Phase:
2
First Approval:
None
UNII:
W7KQU075CV
Molecule Type:
Small molecule
Molecular Formula:
C16H12FN3O3
Molecular Weight:
313.29
AlogP:
2.91
PSA:
92.01
HBD:
2.0
HBA:
#RotB:
5.0
Source:
THYMIDINE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
THYMIDINE
×
Maximum Phase:
2
First Approval:
None
UNII:
VC2W18DGKR
Molecule Type:
Small molecule
Molecular Formula:
C10H14N2O5
Molecular Weight:
242.23
AlogP:
-1.51
PSA:
104.55
HBD:
3.0
HBA:
#RotB:
2.0
Source:
GSK-1292263
(2)
Small molecule
Glucose-dependent insulinotropic receptor agonist
Unknown
Investigational
Unknown
GSK-1292263
×
Maximum Phase:
2
First Approval:
None
UNII:
R1J57STA6O
Molecule Type:
Small molecule
Molecular Formula:
C23H28N4O4S
Molecular Weight:
456.57
AlogP:
3.95
PSA:
98.42
HBD:
0.0
HBA:
#RotB:
7.0
Source:
ACEBILUSTAT
(2)
Small molecule
Leukotriene A4 hydrolase inhibitor
Unknown
Investigational
Unknown
ACEBILUSTAT
×
Maximum Phase:
2
First Approval:
None
UNII:
J64RI4D29U
Molecule Type:
Small molecule
Molecular Formula:
C29H27N3O4
Molecular Weight:
481.55
AlogP:
5.29
PSA:
79.04
HBD:
1.0
HBA:
#RotB:
8.0
Source:
3,5-DIIODOTHYROPROPIONIC ACID
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
3,5-DIIODOTHYROPROPIONIC ACID
×
Maximum Phase:
2
First Approval:
None
UNII:
1HTO2X0SJ9
Molecule Type:
Small molecule
Molecular Formula:
C15H12I2O4
Molecular Weight:
510.07
AlogP:
4.41
PSA:
66.76
HBD:
2.0
HBA:
#RotB:
5.0
Source:
MIRAMISTIN ION
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
MIRAMISTIN ION
×
Maximum Phase:
2
First Approval:
None
UNII:
62S6VPY15U
Molecule Type:
Small molecule
Molecular Formula:
C26H47N2O+
Molecular Weight:
403.68
AlogP:
6.47
PSA:
29.1
HBD:
1.0
HBA:
#RotB:
18.0
Source:
SULCARDINE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
SULCARDINE
×
Maximum Phase:
2
First Approval:
None
UNII:
4Q5HLV8HG1
Molecule Type:
Small molecule
Molecular Formula:
C24H33N3O4S
Molecular Weight:
459.61
AlogP:
3.07
PSA:
82.11
HBD:
2.0
HBA:
#RotB:
9.0
Source:
BATOPROTAFIB
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
BATOPROTAFIB
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FOSDAGROCORAT
(2)
Small molecule
Glucocorticoid receptor modulator
Unknown
Investigational
Unknown
FOSDAGROCORAT
×
Maximum Phase:
2
First Approval:
None
UNII:
HPI19004QS
Molecule Type:
Small molecule
Molecular Formula:
C29H30F3N2O5P
Molecular Weight:
574.54
AlogP:
6.28
PSA:
108.75
HBD:
3.0
HBA:
#RotB:
6.0
Source:
TRIDECANOATE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
TRIDECANOATE
×
Maximum Phase:
2
First Approval:
None
UNII:
19936LIY2V
Molecule Type:
Small molecule
Molecular Formula:
C13H26O2
Molecular Weight:
214.35
AlogP:
4.38
PSA:
37.3
HBD:
1.0
HBA:
#RotB:
11.0
Source:
BRANEBRUTINIB
(2)
Small molecule
Tyrosine-protein kinase BTK inhibitor
Unknown
Investigational
Unknown
BRANEBRUTINIB
×
Maximum Phase:
2
First Approval:
None
UNII:
7LBRZUYSHU
Molecule Type:
Small molecule
Molecular Formula:
C20H23FN4O2
Molecular Weight:
370.43
AlogP:
2.13
PSA:
91.22
HBD:
3.0
HBA:
#RotB:
3.0
Source:
INCB-40093
(2)
Small molecule
PI3-kinase p110-delta subunit inhibitor
Unknown
Investigational
Unknown
INCB-40093
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
.ALPHA.-R-LIPOIC ACID CHOLINE ESTER CHLORIDE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
.ALPHA.-R-LIPOIC ACID CHOLINE ESTER CHLORIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
6HBG94710Z
Molecule Type:
Small molecule
Molecular Formula:
C13H26ClNO2S2
Molecular Weight:
327.94
AlogP:
2.95
PSA:
26.3
HBD:
0.0
HBA:
#RotB:
8.0
Source:
LANIQUIDAR
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
LANIQUIDAR
×
Maximum Phase:
2
First Approval:
None
UNII:
K3FRN4DDOY
Molecule Type:
Small molecule
Molecular Formula:
C37H36N4O3
Molecular Weight:
584.72
AlogP:
6.49
PSA:
69.48
HBD:
0.0
HBA:
#RotB:
7.0
Source:
BRADANICLINE
(2)
Small molecule
Neuronal acetylcholine receptor protein alpha-7 subunit agonist
Unknown
Investigational
Unknown
BRADANICLINE
×
Maximum Phase:
2
First Approval:
None
UNII:
UM3821998K
Molecule Type:
Small molecule
Molecular Formula:
C22H23N3O2
Molecular Weight:
361.45
AlogP:
3.26
PSA:
58.37
HBD:
1.0
HBA:
#RotB:
4.0
Source:
ALLANTOIN
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
ALLANTOIN
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DEFERITAZOLE MAGNESIUM
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
DEFERITAZOLE MAGNESIUM
×
Maximum Phase:
2
First Approval:
None
UNII:
BG3Q8O5L5B
Molecule Type:
Small molecule
Molecular Formula:
C18H25MgNO8S
Molecular Weight:
439.77
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
FAXELADOL
(2)
Small molecule
Mu opioid receptor agonist
Unknown
Investigational
Unknown
FAXELADOL
×
Maximum Phase:
2
First Approval:
None
UNII:
C04V6SGK8H
Molecule Type:
Small molecule
Molecular Formula:
C15H23NO
Molecular Weight:
233.35
AlogP:
3.23
PSA:
23.47
HBD:
1.0
HBA:
#RotB:
3.0
Source:
SODIUM GLYCIDIDAZOLE
(2)
Small molecule
Unknown
Unknown
Approved
Unknown
SODIUM GLYCIDIDAZOLE
×
Maximum Phase:
2
First Approval:
None
UNII:
5YV419FIJS
Molecule Type:
Small molecule
Molecular Formula:
C18H22N7NaO10
Molecular Weight:
519.4
AlogP:
-0.31
PSA:
215.06
HBD:
1.0
HBA:
#RotB:
14.0
Source:
PREXASERTIB
(2)
Small molecule
Serine/threonine-protein kinase Chk1 inhibitor
Unknown
Investigational
Unknown
PREXASERTIB
×
Maximum Phase:
2
First Approval:
None
UNII:
820NH671E6
Molecule Type:
Small molecule
Molecular Formula:
C18H19N7O2
Molecular Weight:
365.4
AlogP:
2.22
PSA:
134.76
HBD:
3.0
HBA:
#RotB:
8.0
Source:
N,N-DIMETHYLTRYPTAMINE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
N,N-DIMETHYLTRYPTAMINE
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
VANILLYL ALCOHOL
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
VANILLYL ALCOHOL
×
Maximum Phase:
2
First Approval:
None
UNII:
X7EA1JUA6M
Molecule Type:
Small molecule
Molecular Formula:
C8H10O3
Molecular Weight:
154.16
AlogP:
0.89
PSA:
49.69
HBD:
2.0
HBA:
#RotB:
2.0
Source:
LUMINESPIB
(2)
Small molecule
Heat shock protein HSP90 inhibitor
Unknown
Investigational
Unknown
LUMINESPIB
×
Maximum Phase:
2
First Approval:
None
UNII:
C6V1DAR5EB
Molecule Type:
Small molecule
Molecular Formula:
C26H31N3O5
Molecular Weight:
465.55
AlogP:
4.13
PSA:
108.06
HBD:
3.0
HBA:
#RotB:
7.0
Source:
RIMIDUCID
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
RIMIDUCID
×
Maximum Phase:
2
First Approval:
None
UNII:
H564L1W5J2
Molecule Type:
Small molecule
Molecular Formula:
C78H98N4O20
Molecular Weight:
1411.65
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
TANZISERTIB
(2)
Small molecule
c-Jun N-terminal kinase 1 inhibitor
Unknown
Investigational
Unknown
TANZISERTIB
×
Maximum Phase:
2
First Approval:
None
UNII:
M5O06306UO
Molecule Type:
Small molecule
Molecular Formula:
C21H23F3N6O2
Molecular Weight:
448.45
AlogP:
3.66
PSA:
97.12
HBD:
3.0
HBA:
#RotB:
5.0
Source:
CICLETANINE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
CICLETANINE
×
Maximum Phase:
2
First Approval:
None
UNII:
CHG7QC509W
Molecule Type:
Small molecule
Molecular Formula:
C14H12ClNO2
Molecular Weight:
261.71
AlogP:
3.37
PSA:
42.35
HBD:
1.0
HBA:
#RotB:
1.0
Source:
DS-1001B
(2)
Small molecule
Isocitrate dehydrogenase [NADP] cytoplasmic inhibitor
Unknown
Investigational
Unknown
DS-1001B
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C29H29Cl3FN3O4
Molecular Weight:
608.93
AlogP:
7.56
PSA:
85.33
HBD:
1.0
HBA:
#RotB:
5.0
Source:
CAPROMORELIN
(2)
Small molecule
Ghrelin receptor agonist
Unknown
Investigational
Unknown
CAPROMORELIN
×
Maximum Phase:
2
First Approval:
None
UNII:
0MQ44VUN84
Molecule Type:
Small molecule
Molecular Formula:
C28H35N5O4
Molecular Weight:
505.62
AlogP:
1.71
PSA:
117.33
HBD:
2.0
HBA:
#RotB:
9.0
Source:
REGRELOR DISODIUM
(2)
Small molecule
Purinergic receptor P2Y12 antagonist
Unknown
Investigational
Unknown
REGRELOR DISODIUM
×
Maximum Phase:
2
First Approval:
None
UNII:
6MU6U599QZ
Molecule Type:
Small molecule
Molecular Formula:
C22H23N6Na2O8P
Molecular Weight:
576.41
AlogP:
1.8
PSA:
179.18
HBD:
4.0
HBA:
#RotB:
8.0
Source:
PYRONARIDINE TETRAPHOSPHATE
(2)
Small molecule
Unknown
Unknown
Approved
Unknown
PYRONARIDINE TETRAPHOSPHATE
×
Maximum Phase:
2
First Approval:
None
UNII:
2T289F9ACO
Molecule Type:
Small molecule
Molecular Formula:
C29H44ClN5O18P4
Molecular Weight:
910.04
AlogP:
6.09
PSA:
73.75
HBD:
2.0
HBA:
#RotB:
7.0
Source:
PAVINETANT
(2)
Small molecule
Neurokinin 3 receptor antagonist
Unknown
Investigational
Unknown
PAVINETANT
×
Maximum Phase:
2
First Approval:
None
UNII:
3U471ZVC5K
Molecule Type:
Small molecule
Molecular Formula:
C26H25N3O3S
Molecular Weight:
459.57
AlogP:
5.15
PSA:
88.16
HBD:
2.0
HBA:
#RotB:
7.0
Source:
BMS-754807
(2)
Small molecule
Insulin receptor inhibitor
Unknown
Investigational
Unknown
BMS-754807
×
Maximum Phase:
2
First Approval:
None
UNII:
W9E3353E8J
Molecule Type:
Small molecule
Molecular Formula:
C23H24FN9O
Molecular Weight:
461.51
AlogP:
3.61
PSA:
116.13
HBD:
3.0
HBA:
#RotB:
6.0
Source:
1
2
…
125
126
127
128
129
130
131
…
221
222
Next »
Download Option
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA